Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Clinical trial NCT04220684 · COMPLETED

Trial details

NCT number: NCT04220684
Sponsor: Sumithira Vasu
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic Stem Cell Transplant Recipient Blasts 10 Percent or More of Bone Marrow Nucleated Cells Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2020-06-11
Primary completion: 2024-10-22
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.